Cadila launches first cheaper copy of world's top-selling drug

Drugmaker Cadila Healthcare Ltd said on Tuesday it launched in India the first biosimilar version of the anti-inflammatory medicine adalimumab, the world's top-selling drug, at a fifth of its U.S. price.

http://in.reuters.com/article/2014/12/09/cadila-health-humira-india-idINKBN0JN0X220141209

YOU ARE BEING REDIRECTED TO THE ARTICLE
. . .
× CLOSE

PROCESSING